Unorthodox Science Fuels Biosphere Space Trial

TUCSON. ARIZ.—Find a wealthy benefactor. Assemble a small group of hard-working people committed to a common goal, and let them teach themselves what they need to know. Enlist a few respected scientists who are kindred spirits. Discourage contact with the outside world. And shoot for the stars. That approach is not the usual way science is done in this country. But then Biosphere II is not run-of-the-mill science. Rather, it's an attempt to create a 2.5-acre, enclosed ecological system th

Written byLouis Weisberg
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

That approach is not the usual way science is done in this country. But then Biosphere II is not run-of-the-mill science. Rather, it's an attempt to create a 2.5-acre, enclosed ecological system that can be a prototype for living communities in space.

It's no surprise that the $30 million project generates strong feelings among scientists in the field. "Some people say the entire group is off-the-wall," acknowledged microbiologist Clair Folsome, director of the Laboratory for Exobiology at the University of Hawaii at Manoa and an unpaid consultant to the group. "The work is considered too kooky to attract any government funding. But I have no doubt that they will succeed."

"I'm amazed they'd take such a large step when we're going at it one meter at a time," said B.C. Wolverton, senior research scientist with NASA's National Space Technology Laboratories near Bay St. Louis, Miss. Wolverton, who has conducted research ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies